First Time Loading...

Penumbra Inc
NYSE:PEN

Watchlist Manager
Penumbra Inc Logo
Penumbra Inc
NYSE:PEN
Watchlist
Price: 204.115 USD 0.55% Market Closed
Updated: Apr 23, 2024

Intrinsic Value

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. [ Read More ]

The intrinsic value of one PEN stock under the Base Case scenario is 95.594 USD. Compared to the current market price of 204.115 USD, Penumbra Inc is Overvalued by 53%.

Key Points:
PEN Intrinsic Value
Base Case
95.594 USD
Overvaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Penumbra Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PEN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Penumbra Inc

Provide an overview of the primary business activities
of Penumbra Inc.

What unique competitive advantages
does Penumbra Inc hold over its rivals?

What risks and challenges
does Penumbra Inc face in the near future?

Has there been any significant insider trading activity
in Penumbra Inc recently?

Summarize the latest earnings call
of Penumbra Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Penumbra Inc.

Provide P/S
for Penumbra Inc.

Provide P/E
for Penumbra Inc.

Provide P/OCF
for Penumbra Inc.

Provide P/FCFE
for Penumbra Inc.

Provide P/B
for Penumbra Inc.

Provide EV/S
for Penumbra Inc.

Provide EV/GP
for Penumbra Inc.

Provide EV/EBITDA
for Penumbra Inc.

Provide EV/EBIT
for Penumbra Inc.

Provide EV/OCF
for Penumbra Inc.

Provide EV/FCFF
for Penumbra Inc.

Provide EV/IC
for Penumbra Inc.

Show me price targets
for Penumbra Inc made by professional analysts.

What are the Revenue projections
for Penumbra Inc?

How accurate were the past Revenue estimates
for Penumbra Inc?

What are the Net Income projections
for Penumbra Inc?

How accurate were the past Net Income estimates
for Penumbra Inc?

What are the EPS projections
for Penumbra Inc?

How accurate were the past EPS estimates
for Penumbra Inc?

What are the EBIT projections
for Penumbra Inc?

How accurate were the past EBIT estimates
for Penumbra Inc?

Compare the revenue forecasts
for Penumbra Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Penumbra Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Penumbra Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Penumbra Inc compared to its peers.

Compare the P/E ratios
of Penumbra Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Penumbra Inc with its peers.

Analyze the financial leverage
of Penumbra Inc compared to its main competitors.

Show all profitability ratios
for Penumbra Inc.

Provide ROE
for Penumbra Inc.

Provide ROA
for Penumbra Inc.

Provide ROIC
for Penumbra Inc.

Provide ROCE
for Penumbra Inc.

Provide Gross Margin
for Penumbra Inc.

Provide Operating Margin
for Penumbra Inc.

Provide Net Margin
for Penumbra Inc.

Provide FCF Margin
for Penumbra Inc.

Show all solvency ratios
for Penumbra Inc.

Provide D/E Ratio
for Penumbra Inc.

Provide D/A Ratio
for Penumbra Inc.

Provide Interest Coverage Ratio
for Penumbra Inc.

Provide Altman Z-Score Ratio
for Penumbra Inc.

Provide Quick Ratio
for Penumbra Inc.

Provide Current Ratio
for Penumbra Inc.

Provide Cash Ratio
for Penumbra Inc.

What is the historical Revenue growth
over the last 5 years for Penumbra Inc?

What is the historical Net Income growth
over the last 5 years for Penumbra Inc?

What is the current Free Cash Flow
of Penumbra Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Penumbra Inc.

Financials

Balance Sheet Decomposition
Penumbra Inc

Current Assets 915.4m
Cash & Short-Term Investments 289.2m
Receivables 201.8m
Other Current Assets 424.4m
Non-Current Assets 640.9m
PP&E 292.5m
Intangibles 237.3m
Other Non-Current Assets 111m
Current Liabilities 151.1m
Accounts Payable 27.2m
Accrued Liabilities 114.8m
Other Current Liabilities 9.2m
Non-Current Liabilities 226.2m
Long-Term Debt 23.7m
Other Non-Current Liabilities 202.5m
Efficiency

Earnings Waterfall
Penumbra Inc

Revenue
1.1B USD
Cost of Revenue
-375.9m USD
Gross Profit
682.6m USD
Operating Expenses
-590.9m USD
Operating Income
91.8m USD
Other Expenses
-812k USD
Net Income
91m USD

Free Cash Flow Analysis
Penumbra Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

PEN Profitability Score
Profitability Due Diligence

Penumbra Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROIC is Increasing
50/100
Profitability
Score

Penumbra Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

PEN Solvency Score
Solvency Due Diligence

Penumbra Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Penumbra Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PEN Price Targets Summary
Penumbra Inc

Wall Street analysts forecast PEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PEN is 284.815 USD with a low forecast of 242.4 USD and a high forecast of 336 USD.

Lowest
Price Target
242.4 USD
19% Upside
Average
Price Target
284.815 USD
40% Upside
Highest
Price Target
336 USD
65% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PEN Price
Penumbra Inc

1M 1M
-7%
6M 6M
-1%
1Y 1Y
-29%
3Y 3Y
-31%
5Y 5Y
+56%
10Y 10Y
+580%
Annual Price Range
204.115
52w Low
181.44
52w High
344.06
Price Metrics
Average Annual Return 18%
Standard Deviation of Annual Returns 35.06%
Max Drawdown -63%
Shares Statistics
Market Capitalization 7.9B USD
Shares Outstanding 39 291 044
Percentage of Shares Shorted 7.08%

PEN Return Decomposition
Main factors of price return

What is price return decomposition?

PEN News

Other Videos

Company Profile

Penumbra Inc Logo
Penumbra Inc

Country

United States of America

Industry

Health Care

Market Cap

7.9B USD

Dividend Yield

0%

Description

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. The company is headquartered in Alameda, California and currently employs 3,800 full-time employees. The company went IPO on 2015-09-18. The firm designs, develops, manufactures, and markets products and has a portfolio that focuses on medical conditions in markets with unmet need. The company is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers. The company is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. The company has developed a product portfolio that includes seven product families within its major markets, in which its neuro products include Thrombectomy, Embolization, Access, and Neurosurgical Tools. Its vascular products include Thrombectomy and Embolization. The firm's immersive healthcare product is Immersive 3D Computer-based Technology Platform. The firm sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, and Australia.

Contact

CALIFORNIA
Alameda
1 Penumbra
+15109952486.0
http://www.penumbrainc.com/

IPO

2015-09-18

Employees

3 800

Officers

Co-Founder, Chairman, President & CEO
Mr. Adam Elsesser
Co-Founder & Director
Dr. Arani Bose M.D.
Chief Financial Officer
Ms. Maggie S. Yuen
Chief Accounting Officer
Mr. Lambert Shiu
Executive VP, General Counsel & Secretary
Ms. Johanna Roberts
Executive Vice President of Operations
Mr. Ben Sorci
Show More
Executive VP & Chief Information Officer
Mr. Pankaj Tiwari
Investor Relations Officer
Ms. Jee Hamlyn-Harris
Executive Vice President of Development
Mr. Ben Tompkins
President of Immersive Healthcare
Ms. Gita Barry
Show Less

See Also

Discover More
What is the Intrinsic Value of one PEN stock?

The intrinsic value of one PEN stock under the Base Case scenario is 95.594 USD.

Is PEN stock undervalued or overvalued?

Compared to the current market price of 204.115 USD, Penumbra Inc is Overvalued by 53%.